Representing uncertainty: the role of cost‐effectiveness acceptability curves
Top Cited Papers
- 20 July 2001
- journal article
- Published by Wiley in Health Economics
- Vol. 10 (8) , 779-787
- https://doi.org/10.1002/hec.635
Abstract
Decision-making in health care is inevitably undertaken in a context of uncertainty concerning the effectiveness and costs of health care interventions and programmes. One method that has been suggested to represent this uncertainty is the cost-effectiveness acceptability curve. This technique, which directly addresses the decision-making problem, has advantages over confidence interval estimation for incremental cost-effectiveness ratios. However, despite these advantages, cost-effectiveness acceptability curves have yet to be widely adopted within the field of economic evaluation of health care technologies. In this paper we consider the relationship between cost-effectiveness acceptability curves and decision-making in health care, suggest the introduction of a new concept more relevant to decision-making, that of the cost-effectiveness frontier, and clarify the use of these techniques when considering decisions involving multiple interventions. We hope that as a result we can encourage the greater use of these techniques.Keywords
This publication has 16 references indexed in Scilit:
- Definition, interpretation and calculation of cost-effectiveness acceptability curvesHealth Economics, 2000
- Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)BMJ, 2000
- Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.PharmacoEconomics, 2000
- A Bayesian approach to stochastic cost-effectiveness analysisHealth Economics, 1999
- Handling uncertainty when performing economic evaluation of healthcare interventions.Health Technology Assessment, 1999
- Confidence intervals or surfaces? Uncertainty on the cost-effectiveness planeHealth Economics, 1998
- Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40BMJ, 1998
- Going beyond the single number: Using probabilistic risk assessment to improve risk managementHuman and Ecological Risk Assessment: An International Journal, 1996
- The Decision Rules of Cost-Effectiveness AnalysisPharmacoEconomics, 1996
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994